Kadil, Adel N.
HRN: 21-68-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2022
CEFTRIAXONE 1G (VIAL)
07/18/2022
07/24/2022
IVT
675mg
Q12
T/C Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes